Views & Analysis How can the UK improve in clinical research? A biotech persp... The UK is a great place for early-stage research – but NHS red tape and market access remain major barriers.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
